1. Home
  2. OSUR vs JRVR Comparison

OSUR vs JRVR Comparison

Compare OSUR & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSUR
  • JRVR
  • Stock Information
  • Founded
  • OSUR 2000
  • JRVR 2002
  • Country
  • OSUR United States
  • JRVR Bermuda
  • Employees
  • OSUR N/A
  • JRVR N/A
  • Industry
  • OSUR Medical/Dental Instruments
  • JRVR Property-Casualty Insurers
  • Sector
  • OSUR Health Care
  • JRVR Finance
  • Exchange
  • OSUR Nasdaq
  • JRVR Nasdaq
  • Market Cap
  • OSUR 223.0M
  • JRVR 189.0M
  • IPO Year
  • OSUR 1986
  • JRVR 2005
  • Fundamental
  • Price
  • OSUR $2.54
  • JRVR $4.75
  • Analyst Decision
  • OSUR Hold
  • JRVR Buy
  • Analyst Count
  • OSUR 2
  • JRVR 4
  • Target Price
  • OSUR $5.50
  • JRVR $6.06
  • AVG Volume (30 Days)
  • OSUR 444.5K
  • JRVR 223.4K
  • Earning Date
  • OSUR 05-07-2025
  • JRVR 05-05-2025
  • Dividend Yield
  • OSUR N/A
  • JRVR 0.83%
  • EPS Growth
  • OSUR N/A
  • JRVR N/A
  • EPS
  • OSUR N/A
  • JRVR N/A
  • Revenue
  • OSUR $161,626,000.00
  • JRVR $678,788,000.00
  • Revenue This Year
  • OSUR N/A
  • JRVR $8.29
  • Revenue Next Year
  • OSUR $7.55
  • JRVR $5.62
  • P/E Ratio
  • OSUR N/A
  • JRVR N/A
  • Revenue Growth
  • OSUR N/A
  • JRVR N/A
  • 52 Week Low
  • OSUR $2.69
  • JRVR $3.00
  • 52 Week High
  • OSUR $5.59
  • JRVR $9.13
  • Technical
  • Relative Strength Index (RSI)
  • OSUR 29.00
  • JRVR 60.41
  • Support Level
  • OSUR $2.42
  • JRVR $4.54
  • Resistance Level
  • OSUR $3.09
  • JRVR $5.15
  • Average True Range (ATR)
  • OSUR 0.10
  • JRVR 0.19
  • MACD
  • OSUR -0.03
  • JRVR 0.03
  • Stochastic Oscillator
  • OSUR 20.60
  • JRVR 56.12

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

Share on Social Networks: